Chugai Pharmaceutical Co(MX:4519N)
MX$743.630.00 (0.00%)
MX:4519N
Chugai Pharmaceutical Co earnings date
MX$743.63
At close:0.00 (0.00%)
Chugai Pharmaceutical Co (4519N) Q3 2024 Earnings Report
0 Followers
MX:4519N Q3 2024 EPS Results
- Actual EPS
- MXN 7.95
- Consensus EPS
- MXN 7.22
- Beat/Miss
- Beat by +MXN 0.73
- One Year Ago EPS
- MXN 5.63
MX:4519N Q3 2024 Revenue Results
- Actual Revenue
- MXN 37.71B
- Expected Revenue
- MXN 35.41B
- Beat/Miss
- Beat by +MXN 2.30B
- YoY Revenue Growth
- +22.40%
Earnings Announcement Details
- Quarter
- Q3 2024
- Date
- 10/25/2024
- Time
- Before Open
- Conference Call
- Friday, October 25, 2024
MX:4519N Upcoming Earnings
Chugai Pharmaceutical Co's next earnings date is estimated for February 4, 2027, based on past reporting schedules.
Q3 2024 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2024 Earnings Slide Deck
Q3 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:4519N Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 04, 2027 | 2026 (Q4) | 9.30- | 9.32 | ― | ― |
| Oct 27, 2026 | 2026 (Q3) | 9.1611.10 | 9.12 | 21.81% (+1.99) | |
| Jul 24, 2026 | 2026 (Q2) | 9.048.22 | 6.91 | 18.95% (+1.31) | |
| Apr 24, 2026 | 2026 (Q1) | 7.938.38 | 7.06 | 18.68% (+1.32) | |
| Jan 29, 2026 | 2025 (Q4) | 8.849.32 | 6.65 | 40.24% (+2.67) | |
| Oct 24, 2025 | 2025 (Q3) | 8.919.12 | 7.95 | 14.67% (+1.17) | |
| Jul 24, 2025 | 2025 (Q2) | 8.856.91 | 8.12 | -14.93% (-1.21) | |
| Apr 24, 2025 | 2025 (Q1) | 6.097.06 | 5.4 | 30.67% (+1.66) | |
| Jan 30, 2025 | 2024 (Q4) | 7.056.65 | 6.62 | 0.37% (+0.02) | |
| Oct 25, 2024 | 2024 (Q3) | 7.227.95 | 5.63 | 41.15% (+2.32) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
